Literature DB >> 35809098

Whole body imaging in musculoskeletal oncology: when, why, and how.

Joao R T Vicentini1, Miriam A Bredella2.   

Abstract

The use of whole-body imaging has become increasingly popular in oncology due to the possibility of evaluating total tumor burden with a single imaging study. This is particularly helpful in cases of widespread disease where dedicated regional imaging would make the evaluation more expensive, time consuming, and prone to more risks. Different techniques can be used, including whole-body MRI, whole-body CT, and PET-CT. Common indications include surveillance of cancer predisposing syndromes, evaluation of osseous metastases and clonal plasma cell disorders such as multiple myeloma, and evaluation of soft tissue lesions, including peripheral nerve sheath tumors. This review focuses on advanced whole-body imaging techniques and their main uses in musculoskeletal oncology.
© 2022. The Author(s), under exclusive licence to International Skeletal Society (ISS).

Entities:  

Keywords:  Metastasis; Multiple myeloma; Neurofibromatosis; PET-CT; Whole-body CT; Whole-body MRI

Year:  2022        PMID: 35809098     DOI: 10.1007/s00256-022-04112-7

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  76 in total

Review 1.  Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.

Authors:  Ashkan Heshmatzadeh Behzadi; Syed Imran Raza; John A Carrino; Christos Kosmas; Ali Gholamrezanezhad; Kyle Basques; George R Matcuk; Jay Patel; Hossein Jadvar
Journal:  PET Clin       Date:  2018-08-17

2.  Whole-body MRI: a practical guide for imaging patients with malignant bone disease.

Authors:  J M Winfield; M D Blackledge; N Tunariu; D-M Koh; C Messiou
Journal:  Clin Radiol       Date:  2021-04-29       Impact factor: 2.350

Review 3.  Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.

Authors:  Alípio G Ormond Filho; Bruno C Carneiro; Daniel Pastore; Igor P Silva; Sâmia R Yamashita; Flávio D Consolo; Vânia T M Hungria; Alex F Sandes; Edgar G Rizzatti; Marcelo A C Nico
Journal:  Radiographics       Date:  2019 Jul-Aug       Impact factor: 5.333

Review 4.  International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.

Authors:  Jens Hillengass; Saad Usmani; S Vincent Rajkumar; Brian G M Durie; María-Victoria Mateos; Sagar Lonial; Cristina Joao; Kenneth C Anderson; Ramón García-Sanz; Eloísa Riva; Juan Du; Niels van de Donk; Jesús G Berdeja; Evangelos Terpos; Elena Zamagni; Robert A Kyle; Jesús San Miguel; Hartmut Goldschmidt; Sergio Giralt; Shaji Kumar; Noopur Raje; Heinz Ludwig; Enrique Ocio; Rik Schots; Hermann Einsele; Fredrik Schjesvold; Wen-Ming Chen; Niels Abildgaard; Brea C Lipe; Dominik Dytfeld; Baldeep Mona Wirk; Matthew Drake; Michele Cavo; Juan José Lahuerta; Suzanne Lentzsch
Journal:  Lancet Oncol       Date:  2019-06       Impact factor: 41.316

Review 5.  Role of FDG PET in the staging of multiple myeloma.

Authors:  Joao R T Vicentini; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2021-04-04       Impact factor: 2.199

Review 6.  Evaluation of osseous metastasis in bone scintigraphy.

Authors:  Diego Davila; Alexander Antoniou; Muhammad A Chaudhry
Journal:  Semin Nucl Med       Date:  2015-01       Impact factor: 4.446

Review 7.  Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques.

Authors:  Laura M Fayad; Michael A Jacobs; Xin Wang; John A Carrino; David A Bluemke
Journal:  Radiology       Date:  2012-11       Impact factor: 11.105

Review 8.  Current and Emerging Roles of Whole-Body MRI in Evaluation of Pediatric Cancer Patients.

Authors:  Ravi V Gottumukkala; Michael S Gee; Perry J Hampilos; Mary-Louise C Greer
Journal:  Radiographics       Date:  2019-01-25       Impact factor: 5.333

9.  Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).

Authors:  Christina Messiou; Jens Hillengass; Stefan Delorme; Frédéric E Lecouvet; Lia A Moulopoulos; David J Collins; Matthew D Blackledge; Niels Abildgaard; Brian Østergaard; Heinz-Peter Schlemmer; Ola Landgren; Jon Thor Asmussen; Martin F Kaiser; Anwar Padhani
Journal:  Radiology       Date:  2019-02-26       Impact factor: 11.105

10.  Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Authors:  Shivani Ahlawat; Laura M Fayad; Muhammad Shayan Khan; Miriam A Bredella; Gordon J Harris; D Gareth Evans; Said Farschtschi; Michael A Jacobs; Avneesh Chhabra; Johannes M Salamon; Ralph Wenzel; Victor F Mautner; Eva Dombi; Wenli Cai; Scott R Plotkin; Jaishri O Blakeley
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.